Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute

Hepato-Gastroenterology

Volumn 59, Issue 115, 2012, Pages 911-915

  Nanashima, Atsushi ^a   Tobinaga, Syuuichi ^a   Abo, Takafumi ^a   Hatano, Kazuhiko ^a   Takeshita, Hiroaki ^a   Nonaka, Takashi ^a   Hidaka, Shigekazu ^a   Tanaka, Kenji ^a   Kunizaki, Masaki ^a   Sawai, Terumitsu ^a   Yasutake, Toru ^a   Nagayasu, Takeshi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Curability; Distal pancreatectomy; Pancreatic carcinoma; Pancreatoduodenectomy

Indexed keywords

GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; TS 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INFILTRATION; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA IN SITU; DISEASE FREE SURVIVAL; FEMALE; HUMAN; JAPAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCINOUS CARCINOMA; OVERALL SURVIVAL; PANCREAS CARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADENOCARCINOMA, MUCINOUS; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; JAPAN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84860542959     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge10038     Document Type: Article

References (34)

1. Winter JM, Cameron JL, Campbell KA, et al.: 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg 2006; 10:1199-1210.
2. Kato K, Yamada S, Sugimoto H, et al.: Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival. Pancreas 2009; 38:605-612.
3. Kazanjian KK, Hines OJ, Duffy JP, Yoon DY, Cortina G, Reber HA: Improved survival following pancreaticoduodenectomy to treat adenocarcinoma of the pancreas: The influence of operative blood loss. Arch Surg 2008; 143:1166-1171.
4. Howard TJ, Krug JE, Yu J, et al.: A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 2006; 10:1338-1345.
5. Hirano S, Kondo S, Hara T, et al.: Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results. Ann Surg 2007; 246:46-51. (Pubitemid 47012206)
6. Kato K, Yamada S, Sugimoto H, et al.: Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival. Pancreas 2009; 38:605-612.
7. Hellan M, Sun CL, Artinyan A, et al.: The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer. Pancreas 2008; 37:19-24.
8. Yeo CJ, Cameron JL, Lillemoe KD, et al.: Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity and mortality. Ann Surg 2002; 236:355-366.
9. Lockhart AC, Rothenberg ML, Berlin JD: Treatment for pancreatic cancer: current therapy and continued progress. Gastroenterology 2005; 128:1642-1654. (Pubitemid 40692557)
10. Sata N, Kurashina K, Nagai H, et al.: The effect of adjuvant and neoadjuvant chemo(radio)therapy on survival in 1,679 resected pancreatic carcinoma cases in Japan: report of the national survey in the 34th annual meeting of Japanese Society of Pancreatic Surgery. J Hepatobiliary Pancreat Surg 2009; 16:485-492.
11. Japan Pancreas Society. In: Kawarada Y ed. Classification of Pancreatic Carcinoma. 2nd Englsih ed., Tokyo: Kanehara & Co., Ltd., 2003:4-33.
12. Yekebas EF, Bogoevski D, Cataldegirmen G, et al.: En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg 2008; 247:300-309. (Pubitemid 351156774)
13. Pratt WB, Gangavati A, Agarwal K, et al.: Establishing standards of quality for elderly patients undergoing pancreatic resection. Arch Surg. 2009; 144:950-956.
14. Delbeke D, Pinson CW: Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment. J Hepatobiliary Pancreat Surg 2004; 11:4-10. (Pubitemid 38404325)
15. Boujaoude J: Role of endoscopic ultrasound in diagnosis and therapy of pancreatic adenocarcinoma. World J Gastroenterol 2007; 13:3662-3666.
16. Sakamoto H, Kitano M, Komaki T, et al.: Small invasive ductal carcinoma of the pancreas distinct from branch duct intraductal papillary mucinous neoplasm. World J Gastroenterol 2009; 15:5489-5492.
17. Kala Z, Válek V, Hlavsa J, Hana K, Vánová A: The role of CT and endoscopic ultrasound in pre-operative staging of pancreatic cancer. Eur J Radiol 2007; 62:166-169. (Pubitemid 46560350)
18. Sandha GS, Severin D, Postema E, McEwan A, Stewart K: Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography, and EUS. Gastrointest Endosc 2008; 67:402-409.
19. Shimada K, Sakamoto Y, Sano T, Kosuge T: The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma. J Am Coll Surg 2006; 203:345-352. (Pubitemid 44247756)
20. Hirata K, Egawa S, Kimura Y, et al.: Current status of surgery for pancreatic cancer. Dig Surg 2007; 24:137-147. (Pubitemid 46788281)
21. Amano H, Miura F, Toyota N, et al.: Is pancreatectomy with arterial reconstruction a safe and useful procedure for locally advanced pancreatic cancer? J Hepatobiliary Pancreat Surg 2009; 16:850-857.
22. Yang YM, Tian XD, Zhuang Y, Wang WM, Wan YL, Huang YT: Risk factors of pancreatic leakage after pancreaticoduodenectomy. World J Gastroenterol 2005; 11:2456-2461. (Pubitemid 40667981)
23. Kato K, Yamada S, Sugimoto H, et al.: Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival. Pancreas 2009; 38:605-612.
24. Hernandez J, Mullinax J, Clark W, et al.: Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins. Ann Surg 2009; 250:76-80.
25. Waraya M, Yamashita K, Katagiri H, Ishii K, Takahashi Y, Furuta K, Watanabe M: Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer. Ann Surg Oncol 2009; 16:1231-1240.
26. Togawa A, Yoshitomi H, Ito H, et al.: Treatment with an oral fluoropyrimidine, S-1, plus cisplatin in patients who failed postoperative gemcitabine treatment for pancreatic cancer: a pilot study. Int J Clin Oncol 2007; 12:268-273. (Pubitemid 47262737)
27. Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Ohge H, Sueda T: Impact of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for adenocarcinoma of the body or tail of the pancreas. J Gastrointest Surg 2009; 13:85-92.
28. Nakao A, Fujii T, Sugimoto H, et al.: Oncological problems in pancreatic cancer surgery. World J Gastroenterol 2006; 12:4466-4472. (Pubitemid 44256331)
29. Kazanjian KK, Hines OJ, Duffy JP, Yoon DY, Cortina G, Reber HA: Improved survival following pancreaticoduodenectomy to treat adenocarcinoma of the pancreas: the influence of operative blood loss. Arch Surg 2008; 143:1166-1171.
30. Reni M, Cereda S, Balzano G, et al.: Carbohydrate antigen 19-9 change during chemotherapy for advanced pancreatic adenocarcinoma. Cancer 2009; 115:2630-2639.
31. Ishida M, Egawa S, Aoki T, et al.: Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas. Pancreas 2007; 35:348-352. (Pubitemid 350307378)
32. Waters JA, Schmidt CM: Intraductal papillary mucinous neoplasm-when to resect? Adv Surg 2008; 42:87-108.
33. Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Yoon YB: Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma. Pancreas 2008; 36:50-55.
34. Nanashima A, Sumida Y, Abo T, et al.: Surgical experiences of intraductal papillary mucinous neoplasms of the pancreas at a single Japanese institute: characteristics of malignant histology. Hepato-gastroenterol 2008; 55:2238-2241.